FENC - Fennec Pharmaceuticals Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
8.34 0.38 (4.56%)	---	---	---	---	0.38 (4.56%)	---	---

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.11
Diluted EPS:: -0.11
Basic P/E:: -79.2727
Diluted P/E:: -79.2727
RSI(14) 1m:: 59.57
VWAP:: 8.74
RVol:: 0.3516

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	8.65 +0.11 (+1.32%)	Oct 15 14:26
1m	Price increase 1m	8.62 +0.1 (+1.18%)	Oct 15 14:25
1m	Price increase 1m	8.64 +0.14 (+1.65%)	Oct 15 14:24
1m	Price increase 1m	8.46 +0.12 (+1.44%)	Oct 15 09:30